Sponsor

Alkahest, Inc.

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Alkahest, Inc. appears in 6 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials6
Recruiting shown0
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

6 shown
A Study to Evaluate the Efficacy of Oral AKST4290 in Participants With Moderately Severe to Severe Diabetic Retinopathy (CAPRI)NCT05038020 · lead sponsor · 2021-08-17
TERMINATED
Study Assessing Efficacy and Safety of AKST4290 in Subjects With Parkinson's Disease on Stable Dopaminergic TreatmentNCT04369430 · lead sponsor · 2020-01-16
COMPLETED
A Study to Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's DiseaseNCT03765762 · lead sponsor · 2019-01-15
COMPLETED
A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive ImpairmentNCT03713957 · lead sponsor · 2018-11-12
COMPLETED
A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's DiseaseNCT03520998 · lead sponsor · 2018-04-16
COMPLETED
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) StudyNCT02256306 · collaborator · 2014-09-01
COMPLETED

Sponsor roles

lead sponsor5
collaborator1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.